Biofrontera Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.20 | -$1.14 | -$1.17 |
| Q2 2024 | 1 | -$0.79 | -$0.75 | -$0.77 |
| Q3 2024 | 1 | -$0.86 | -$0.81 | -$0.84 |
| Q4 2024 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q1 2025 | 1 | -$0.25 | -$0.24 | -$0.25 |
| Q2 2025 | 1 | -$0.43 | -$0.40 | -$0.42 |
| Q3 2025 | 1 | -$0.33 | -$0.32 | -$0.33 |
| Q4 2025 | 1 | $0.12 | $0.13 | $0.13 |
Biofrontera Inc. Earnings Date And Information
Biofrontera Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.86 earnings per share for the quarter, missing analysts' consensus estimates of $-0.73 by $0.13. The company had revenue of 9.01 M for the quarter and had revenue of 34.07 M for the year. Biofrontera Inc. has generated $-13 earnings per share over the last year ($-13.02 diluted earnings per share) and currently has a price-to-earnings ratio of -0.38. Biofrontera Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 21st, 2025 based on prior year's report dates.
Biofrontera Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.98 | $10.00 M | $9.01 M | ||
| 08/14/2024 | Q2 2024 | -$1.19 | -$0.05 | 1.14 | $8.21 M | $7.84 M |
| 05/15/2024 | Q1 2024 | -$1.63 | -$2.88 | -1.25 | $7.90 M | |
| 03/15/2024 | Q4 2023 | -$1.19 | $1.65 | 2.84 | $10.60 M | |
| 11/09/2023 | Q3 2023 | -$4.23 | -$4.64 | -0.41 | $8.43 M | $8.88 M |
| 08/11/2023 | Q2 2023 | -$5.14 | -$7.23 | -2.09 | $6.20 M | $5.85 M |
| 05/12/2023 | Q1 2023 | -$4.40 | -$5.60 | -1.2 | $8.73 M | |
| 03/13/2023 | Q4 2022 | -$2.60 | -$2.09 | 0.51 | $10.14 M | |
| 11/14/2022 | Q3 2022 | -$6.40 | -$2.26 | 4.14 | $4.30 M | $4.32 M |
| 08/12/2022 | Q2 2022 | -$6.20 | $7.51 | 13.71 | $4.55 M | $4.46 M |
| 05/13/2022 | Q1 2022 | -$2.80 | $6.50 | 9.3 | $9.75 M | |
| 04/08/2022 | Q4 2021 | -$25.90 | $9.17 M | |||
| 11/30/2021 | Q3 2021 | -$11.60 | -$40.03 | -28.43 | $4.86 M | $4.33 M |
| 06/30/2021 | Q2 2021 | -$9.20 | $5.86 M | |||
| 03/31/2021 | Q1 2021 | -$8.84 | $4.74 M | |||
| 12/30/2020 | Q4 2020 | -$0.46 | $8.57 M | |||
| 09/29/2020 | Q3 2020 | -$5.15 | $3.25 M | |||
| 06/29/2020 | Q2 2020 | -$6.25 | $2.40 M | |||
| 03/30/2020 | Q1 2020 | -$6.84 | $4.62 M |
Biofrontera Inc. Earnings: Frequently Asked Questions
-
When is Biofrontera Inc.'s earnings date?
Biofrontera Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 21st, 2025 based off last year's report dates.
-
How can I listen to Biofrontera Inc.'s earnings conference call?
The conference call for Biofrontera Inc.'s latest earnings report can be listened to online.
-
How can I read Biofrontera Inc.'s conference call transcript?
The conference call transcript for Biofrontera Inc.'s latest earnings report can be read online.
-
How much revenue does Biofrontera Inc. generate each year?
Biofrontera Inc. (:BFRI) has a recorded annual revenue of $34.07 M.
-
How much profit does Biofrontera Inc. generate each year?
Biofrontera Inc. (:BFRI) has a recorded net income of $34.07 M. Biofrontera Inc. has generated $-13.02 earnings per share over the last four quarters.
-
What is Biofrontera Inc.'s price-to-earnings ratio?
Biofrontera Inc. (:BFRI) has a price-to-earnings ratio of -0.38 and price/earnings-to-growth ratio is -0.
